Trademarkia Logo

Australia

AU$
THALIDOMIDE PHARMION
Ceased - Not renewed: Renewal fee not paid

Last updated on 14 Dec 2018

Owner Info

Celgene Corporation

86 Morris Avenue

Summit, NJ 07901, UNITED STATES OF AMERICA

Serial Number

1250602 filed on 15 May 2008

Correspondent

Cozen O'connor

One Liberty Place, 1650 Market Street,

Philadelphia PA 19103,

UNITED STATES OF AMERICA

THALIDOMIDE PHARMION

Classification Information


Class [005]
Pharmaceutical preparations containing thalidomide used to treat cancers and immune related diseases

Mark Details


Serial Number

1250602

Registered On

15 May 2008

Renewal On

NA

Mark Type

FIGURATIVE

Priority Claim (Convention Details)


Date

30 Apr 2008

Mark Type

CH

Legal History


Show more

Status DateAction Taken
14th Dec 2018Status change to Removed/Ceased - Not Renewed
29th May 2018Registration Status Change
15th Nov 2017Registration Status Change
10th Sept 2015Amendment to Application/Registration
8th Nov 2011Amend Trade Mark Registration Particulars
29th Jun 2010Goods and Services Classes
29th Jun 2010Goods and Services description amendment
25th Mar 2010General Correspondence Registration
6th Feb 2009Amend Trade Mark Registration Particulars
8th Jan 2009IP Right Registration Published